Efficacy and Safety of Tafolecimab in Chinese Patients With Non-Familial Hypercholesterolemia (CREDIT-1): A 48-Week Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial

被引：0
|
作者：
Huo, Yong
Li, Yong
Zhang, Ping
Deng, Huan
Li, Haoyu
An, Pei
Xue, Fengtai
Yu, Zhongxun
Ma, Qingyang
Qi, Litong
Chen, Beijian
Lian, Qiufang
Lu, Di
Qian, Lei
机构：
来源：
CIRCULATION | 2022年 / 146卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A10111
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Efficacy and Safety of Baclofen for Alcohol Dependence: A Randomized, Double-Blind, Placebo-Controlled Trial
    Garbutt, James C.
    Kampov-Polevoy, Alexei B.
    Gallop, Robert
    Kalka-Juhl, Linda
    Flannery, Barbara A.
    ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2010, 34 (11) : 1849 - 1857
  • [42] Safety and efficacy of tibolone and menopausal transition: a randomized, double-blind placebo-controlled trial
    Maria, Morais-Socorro
    Alvaro, Cavalcanti Maciel
    Rand, Martins
    Paulo, Neto Francisco
    Adriana, Rezende
    George, Azevedo
    Maria, Almeida
    GYNECOLOGICAL ENDOCRINOLOGY, 2012, 28 (06) : 483 - 487
  • [43] Efficacy and safety of oral tolvaptan in patients undergoing hemodialysis: a Phase 2, double-blind, randomized, placebo-controlled trial
    Ogata, Hiroaki
    Shimofurutani, Naoko
    Okada, Tadashi
    Nagamoto, Hisashi
    Akizawa, Tadao
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2021, 36 (06) : 1088 - 1097
  • [44] Safety, tolerability, and pharmacokinetics of ibrexafungerp in healthy Chinese subjects: a randomized, double-blind, placebo-controlled phase 1 trial
    Liu, Xiaoyan
    Zhang, Rui
    Li, Rong
    Wu, Qiong
    Pan, Chao
    Yu, Xiangqing
    Liu, Yuhui
    Wang, Benjie
    Yu, Shuwen
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2023, 67 (12)
  • [45] Efficacy and Safety of Golimumab in Patients With Ankylosing Spondylitis Results of a Randomized, Double-Blind, Placebo-Controlled, Phase III Trial
    Inman, Robert D.
    Davis, John C., Jr.
    van der Heijde, Desiree
    Dickman, Laura
    Sieper, Joachim
    Kim, Sung Il
    Mack, Michael
    Han, John
    Visvanathan, Sudha
    Xu, Zhenhua
    Su, Benjamin
    Beutler, Anna
    Braun, Juergen
    ARTHRITIS AND RHEUMATISM, 2008, 58 (11): : 3402 - 3412
  • [46] Efficacy and Safety of Omilancor in a Phase 2 Randomized, Double-Blind, Placebo-Controlled Trial of Patients With Crohn's Disease
    Chowla, Navreet M.
    Tariq, Raseen
    Aggarwal, Manik
    Loftus, Edward V.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (10): : S820 - S821
  • [47] Efficacy and safety of intramuscular aripiprazole in patients with acute agitation: A randomized, double-blind, placebo-controlled trial
    Tran-Johnson, Tram K.
    Sack, David A.
    Marcus, Ronald N.
    Auby, Philippe
    McQuade, Robert D.
    Oren, Dan A.
    JOURNAL OF CLINICAL PSYCHIATRY, 2007, 68 (01) : 111 - 119
  • [48] Efficacy and Safety of Chuanxiong Qingnao Granule in Patients with Migraine: A Randomized, Double-Blind, Placebo-Controlled Trial
    Li, Yi-Fan
    Hu, Hui-Min
    Wang, Bo-Ning
    Zhang, Yi
    Liu, Xing
    Mao, Peng
    Fan, Bi-Fa
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2021, 2021
  • [49] Efficacy and Safety of Toutongning Capsule in Patients with Migraine: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial
    Yu, Shengyuan
    Ran, Ye
    Wan, Qi
    Yang, Xiaosu
    Chen, Huisheng
    Wang, Hebo
    Hu, Xueqiang
    Mao, Shanping
    Yu, Tingming
    Luo, Guogang
    Guan, Yangtai
    Gao, Xuguang
    Li, Xin
    Zhou, Muke
    Li, Yu
    JOURNAL OF ALTERNATIVE AND COMPLEMENTARY MEDICINE, 2019, 25 (12) : 1215 - 1224
  • [50] The efficacy and safety of eperisone in patients with cervical spondylosis: Results of a randomized, double-blind, placebo-controlled trial
    Bose, K
    METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY, 1999, 21 (03): : 209 - 213
12345